Sonic Healthcare Limited

Sonic Healthcare Limited

SKHHY
Sonic Healthcare LimitedUS flagOther OTC
13.34
USD
-0.15
- -
6.59BMarket Cap
Sonic Healthcare Limited
SKHHY
(Other OTC)

Recent

price

13.34

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
7.59
7.89
8.48
8.67
9.63
10.32
12.05
12.13
12.97
13.54
14.28
18.33
19.49
17.34
18.77
20.03
Revenue per Share
0.76
0.76
0.81
0.85
0.96
0.9
1.1
1.03
1.13
1.22
1.11
2.75
3.05
1.46
1.07
1.07
Basic EPS, GAAP
0.65
0.61
0.79
0.58
0.84
0.62
0.76
0.79
-0.78
-0.86
-0.7
-0.76
-0.79
-1.06
-1.22
-0.96
Free Cash Flow per Basic Share
0.59
0.59
0.59
0.52
0.65
0.7
0.53
0.68
0.57
0.83
0.87
0.89
0.98
1.04
1.17
1.18
Dividend per Share
6.79
6.96
7.23
7.61
8
8.23
8.95
9.32
9.83
11.73
11.37
13.42
15.08
15.75
16.16
16.01
Book Value per Share
-11.03
-10.79
-11.19
-12.01
-2.44
-13.16
-15.4
-3.49
-3.41
-17.22
-16.66
-13.77
-14.47
-15.41
-20.14
-2.69
Tangible Book Value per Share
388
388
390
395
400
401
410
417
422
449
475
477
478
470
476
480
Basic Weighted Avg Shares
2,945
3,064
3,307
3,425
3,855
4,141
4,947
5,054
5,476
6,076
6,783
8,753
9,321
8,145
8,934
9,619
Sales/Revenue/Turnover
13.58
13.99
13.79
13.12
13.47
11.16
11.31
11.39
11.51
11.52
11.24
21.93
22.93
12.21
9.14
9.41
Operating Margin (%)
108
115
132
141
161
179
220
228
256
273
606
642
675
703
777
815
Depreciation Expense
293
295
316
335
385
363
451
428
476
550
528
1,315
1,461
685
511
514
Net Income, GAAP
24.01
24.57
23.99
23.37
24.49
23.88
22.03
23.16
21.38
22.59
22.48
26.3
27.04
23.98
25.57
27.56
Effective Tax Rate (%)
9.96
9.61
9.56
9.78
9.99
8.77
9.12
8.46
8.69
9.05
7.78
15.02
15.67
8.41
5.72
5.34
Profit Margin (%)
-682
114
-933
-927
-108
208
-834
-311
-58
-1,415
-658
-1,144
-677
-598
-621
382
Working Capital
2,702
3,408
2,445
2,874
1,521
4,448
4,197
2,052
5,583
4,418
6,825
4,276
4,248
4,427
6,545
4,710
LT Debt
2,559
2,516
2,610
2,918
3,109
3,342
3,733
3,926
4,283
5,492
5,664
6,504
7,428
7,922
8,075
8,473
Total Equity
4.97
5.33
5.73
5.3
6.54
5.44
5.22
5.6
5.89
5
4.66
11.11
12.88
5.97
4.31
4.52
Return on Invested Capital (%)
5.55
5.64
6
5.74
7.03
6.14
5.86
5.91
6.32
5.71
4.86
10.84
12.44
5.99
4.31
4.06
Return on Capital (%)
11.36
11.04
11.45
11.5
12.4
11.17
12.94
11.32
11.84
11.68
9.9
22.28
21.45
9.38
6.77
6.68
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.99%
8.51%
4.93%
Free Cash Flow
-12.41%
8.2%
-20.16%
Net Income, GAAP
12.4%
16.45%
0.49%
Sales/Revenue/Turnover
9.28%
8.06%
7.67%
Total Cash Common Dividend
9.09%
6.68%
1.33%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
8,145
2024
- -
- -
- -
- -
8,934
2025
- -
- -
- -
- -
9,619

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.46
2024
- -
- -
- -
- -
1.07
2025
- -
- -
- -
- -
1.07

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.04
2024
- -
- -
- -
- -
1.17
2025
- -
- -
- -
- -
1.18
Business
Sonic Healthcare Limited is a global provider of medical diagnostic services headquartered in Sydney, Australia. The company operates primarily in the laboratory medicine, pathology, radiology, and primary care sectors. Its core product offerings include pathology and clinical laboratory services; diagnostic imaging and radiology services; medical center operations under its Independent Practitioner Network (IPN) brand; and occupational health services provided through its Sonic HealthPlus division. Sonic Healthcare's laboratory services span Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, and Belgium. Its radiology services are delivered mainly in Australia, while the Other segment encompasses corporate office functions, healthcare centers, and occupational health services. Founded in 1978, Sonic Healthcare has grown into one of the largest private pathology operators globally, with approximately 42,000 employees and annual revenue of around AUD 9.65 billion as of the 2025 financial year. The company is the largest private pathology operator in Australia, Germany, Switzerland, and the UK; the second-largest in Belgium and New Zealand; and the third-largest in the United States. The company serves a diverse customer base including hospitals, medical practitioners, and occupational health sectors, leveraging its broad geographic footprint to deliver diagnostic and healthcare services. Recent major changes include strategic acquisitions and partnerships that expand its diagnostic and healthcare footprint. In the past two years, Sonic Healthcare has continued growth through acquisitions of pathology and radiology practices, including expansions in the US market with the acquisition of ProPath in Dallas, Texas, and further development of its medical imaging capabilities in Australia with a majority stake acquisition in Epworth Medical Imaging. The company has also pursued strategic partnerships with US health systems such as Baptist Memorial Health Care and NYU Health System to enhance specialized diagnostic services. Additionally, Sonic Healthcare has integrated new digital pathology solutions through investments in artificial intelligence-based pathology services via its acquisition of a stake in Harrison.ai. These moves reflect Sonic Healthcare's strategic focus on expanding its comprehensive diagnostic services and leveraging technology for improved healthcare delivery. Sonic Healthcare operates in the healthcare diagnostics industry, serving hospitals, healthcare providers, corporate clients, and patients across multiple countries, including Australia, New Zealand, the US, UK, Germany, Switzerland, Belgium, and Ireland. The company is publicly listed on the Australian Securities Exchange (ASX) under the ticker SKHHY. Its latest financial reporting shows steady revenue growth, driven mainly by its laboratory services segment, which contributes approximately 85% of total revenue, complemented by growth in radiology and other healthcare services. Sonic Healthcare maintains a broad presence through its subsidiaries and partnerships across key international markets, positioning itself as a leading global diagnostic services provider focused on delivering high-quality pathology, radiology, and primary healthcare services with ongoing innovations and strategic market expansions in recent years.

Company News

APIChat
  • Critical Contrast: Ethema Health (OTCMKTS:GRST) & Sonic Healthcare (OTCMKTS:SKHHY)

  • Sonic Healthcare (OTCMKTS:SKHHY) Shares Pass Below 200 Day Moving Average – Here’s What Happened

  • CochLear (OTCMKTS:CHEOY) and Sonic Healthcare (OTCMKTS:SKHHY) Financial Review

  • Sonic Healthcare (OTCMKTS:SKHHY) and Amplifon (OTCMKTS:AMFPF) Critical Survey

  • Sonic Healthcare Limited (SKHHY) Q2 2026 Earnings Call Transcript

  • Sonic Healthcare (OTCMKTS:SKHHY) Shares Gap Up – Time to Buy?

  • Sonic Healthcare (OTCMKTS:SKHHY) Shares Gap Down – Should You Sell?

  • Sonic Healthcare Limited (SKHHY) Shareholder/Analyst Call Transcript

  • Comparing Sonic Healthcare (OTCMKTS:SKHHY) & InnovAge (NASDAQ:INNV)

  • All You Need to Know About Sonic Healthcare Ltd. Sponsored ADR (SKHHY) Rating Upgrade to Buy

  • Sonic Healthcare Limited (SKHCF) Q4 2025 Earnings Call Transcript

  • Sonic Healthcare Limited (SKHCF) Q2 2025 Earnings Call Transcript

  • Sonic Healthcare Limited (SKHCF) Q2 2024 Earnings Call Transcript